TRAVERSO, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 13.640
Totale 13.640
Nazione #
IT - Italia 13.640
Totale 13.640
Città #
Genova 8.873
Genoa 2.332
Rapallo 1.429
Vado Ligure 994
Bordighera 12
Totale 13.640
Nome #
Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma 219
Chronic ethanol consumption impairs dolichol levels and glycosylation processes in rat liver microsomes and Golgi apparatus 176
Heme oxygenase 1 expression in rat liver during ageing and ethanol intoxication 175
Cholesterol and amyloid-beta: evidence for a cross-talk between astrocytes and neuronal cells 166
GSH loss per se does not affect neuroblastoma survival and is not genotoxic 163
Heme oxygenase-1-derived bilirubin protects endothelial cells against high glucose-induced damage 159
4-Hydroxyhexenal and 4-hydroxynonenal are mediators of the anti-cachectic effect of n-3 and n-6 polyunsaturated fatty acids on human lung cancer cells 159
Diabetes impairs the enzymatic disposal of HNE in rat liver. 154
Structural alterations of human serum albumin caused by glycative and oxidative stressors revealed by circular dichroism analysis 152
Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy 151
Effects of valsartan therapy on protein glycoxidation. 150
Malondialdehyde, a lipoperoxidation-derived aldehyde, can bring about secondary oxidative damage to proteins 149
HO-1 up-regulation: A key point in high-risk neuroblastoma resistance to bortezomib. 148
HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin. 147
Lipoperoxidation is selectively involved in progressive supranuclear palsy 146
PKC delta and NADPH oxidase in neuronal sensitivity to glycoxidative stress 146
Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology? 146
Supplementation with N-acetylcysteine and taurine failed to restore glutathione content in liver of streptozotocin-induced diabetics rats but protected from oxidative stress 146
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 145
Survival rate in Patients affected by Dementia followed by memory clinics (UVA) in Italy 145
Role of Nrf2 in neuroblastoma sensitivity to Bortezomib 144
Early glycoxidation damage in brains from Down’s syndrome 142
RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage 142
The p38MAPK inhibition: A new combined approach to reduce neuroblastoma survival under etoposide treatment 142
Early effects of portal flow modulation after extended liver resection in rat. 141
Role of Nrf2, HO-1 and GSH in neuroblastoma cell resistance to bortezomib 141
Advanced Glycation End-products in neuronal death: role of RAGE and Nrf-2 140
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation 140
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 139
Anti malondialdehyde-adduct immunological response as a possible marker of successful aging 139
Effect of ethanol administration on the level of dolichol in rat liver microsomes and Golgi apparatus 138
Nitric oxide synthase/endothelin-1 ratio is modified by diabetes and elevated glucose and is related to kidney matrix composition 135
Impaired synthesis contributes to diabetes-induced decrease in liver glutathione 133
Human mesangial cells resist glycoxidative stress through an antioxidant response 133
Oxidative stress and antioxidant defence in a healthy nonagenarian population. 132
Effects of competition on acute phase proteins and lymphocyte subpopulations - oxidative stress markers in eventing horses 132
Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1. 131
Cholesterol and Amyloid-β: Evidence for a Cross-Talk between Astrocytes and Neuronal Cells. 128
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance 128
Levels of carbonyl groups in plasma proteins of type 2 diabetes mellitus subjects 126
ATRA-induced neuronal differentiation reduces cell ability to adapt to oxidative stress: role of Nrf2 and HO-1 126
Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease 123
PKC delta and NADPH oxidase in age-induced neuronal death 122
Role of glutathione in cancer progression and chemoresistance 121
p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment 120
Lipoperoxidation in hepatic subcellular compartments of diabetic rats 115
PKC delta and NADPH oxidase in retinoic acid-induced neuroblastoma cell differentiation 115
Role of PKC-delta activity in glutathione-depleted neuroblastoma cells 114
Oxysterol mixture and, in particular, 27-hydroxycholesterol drive M2 polarization of human macrophages 114
MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance 114
Effect of chronic ethanol consumption on glycosylation processes in rat liver microsomes and Golgi apparatus 113
Pentosidine determination in CSF: a potential biomarker of Alzheimer' disease 113
Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma 113
Plasma protein oxidation and antioxidant defense during aging 113
Susceptibility of gamma-irradiated proteins to in vitro glycation: exposure to oxygen free radicals increases glycation-induced modifications 112
Glutathione and the switch of aerobic metabolism collaborate for multi-drug resistance of neuroblastoma 112
Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes 110
Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts 110
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 109
Collagen-linked fluorescence in normal and diabetic rats. 108
Role of HO-1 in neuroblastoma resistance to Bortezomib. 108
Whey proteins influence hepatic glutathione after CCl4 intoxication. 108
Glycoxidative damage in diabetic rats treated with antioxidants 107
Short exposure to high concentrations of malondialdehyde does not mimic physiological conditions 107
Effects of CCl4 poisoning on metabolism of dolichol in rat liver microsomes and Golgi apparatus. 106
p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment. 106
PKC delta and NADPH oxidase in retinoic acid-induced neuroblastoma cell differentiation 105
Immunological evidence for increased oxidative stress in diabetic rats 103
Ruolo degli AGEs e delle metalloproteasi nell'evoluzione di placca aterosclerotica 103
Inhibition of p38MAPK: A Combined Strategy for Sensitizing Neuroblastoma Cells to Etoposide Through the Modulation of Pro-Inflammation Markers. 103
Retinoic acid-induced neuroblastoma differentiation is dependent from NOX activation 102
Role of antioxidants in the protection from diabetic nephropathy 102
Pentosidine determination in CSF: a potential biomarker of Alzheimer's disease? 102
Biochemical and morphologic effects after extended liver resection in rats: preliminary results. 101
Inhibition of Heme Oxygenase-1 sensitizes glutathione-depleted neuroblastoma cells to death 101
Antioxidants prevent renal glycoxidative damage in diabetic rats 100
Doloplus-2 pain assessment:an effective tool in patients over 85 years with advanced dementia and persistent pain 99
Intensive insulin treatment reduces the accumulation of oxidative and glycative end products in diabetic rat collagen 99
Mutual interaction between glycation and oxidation during non enzymatic protein modification 99
Glycation and oxidation end-products fluorescence during aging 98
Relationships between glycation and oxidation related fluorescences in rat collagen during aging: an in vivo and in vitro study 97
Free radicals and fetal disease. 96
Protein kinase C inactivation by Fenton’s-reaction at discrete Cu++ binding sites 96
Induction of heme oxygenase 1 in liver of spontaneously diabetic rats 95
Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons 94
Whey protein, as exclusively nitrogen source, controls food intake and promotes glutathione antioxidant protection in Sprague-Dawley rats 93
CD44/xCT inhibition is a potential strategy to sensitize cancer stem cells to etoposide pro-oxidant effects 92
Glutathione is a key player in the multidrug-resistance of neuroblastoma.https://iris.unige.it/submit?resume=151724&queryId=mysubmissions# 88
Redox state and PKC signalling in neuronal differentiation and sensitivity to glycoxidative stress 87
Oxidative stress in the animal model: The possible protective role of milk serum protein 87
Effetcs of simvastatin on liver and plasma levels of cholesterol, dolichol and ubiquinol in hypercholesterolemic rats 87
Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis 87
Supplementation with antioxidants protects diabetic rats from glycoxidative damage in skin and kidney 84
Good glycemic control reduces oxidation and glycation end-products in collagen of diabetic rats 84
Retinoic acid-induced differentiation modifies neuronal cell response to oxidative stress 83
Effect of chronic ethanol consumption on the glycolipoprotein metabolism in rat liver Golgi apparatus 82
Resistance of Neuroblastoma cell line GI-ME-N to redox unbalance involves Heme Oxygenase-1 82
Influence of chronic ethanol consumption on toxic effects of 1,2-dichloroethane: glycoprotein retention and impairment of dolichol concentration in rat liver microsomes and Golgi apparatus 81
Evidence for multiple modifications of albumin exposed to malondialdehyde 81
Evidence for multiple modifications of albumin exposed to Malondialdehyde 81
Totale 11.981
Categoria #
all - tutte 41.954
article - articoli 38.878
book - libri 0
conference - conferenze 1.449
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.627
Totale 83.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020124 0 0 0 0 0 0 0 0 0 0 0 124
2020/2021728 40 67 53 49 49 65 25 71 82 81 79 67
2021/20221.522 42 121 110 180 92 83 90 352 67 136 59 190
2022/20231.683 152 142 28 196 276 287 5 120 267 7 183 20
2023/2024751 41 111 6 108 59 97 49 34 41 57 67 81
2024/20252.352 50 172 63 177 353 237 205 417 86 114 262 216
Totale 13.822